Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - azathioprine -

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

strides pharma uk ltd - azathioprine - oral tablet - 50mg

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

glenmark pharmaceuticals, inc - azathioprine (unii: mrk240iy2l) (azathioprine - unii:mrk240iy2l) - indications and usage: azathioprine is indicated as an adjunct for the prevention of rejection in renal homotransplantation. it is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms. renal homotransplantation: azathioprine is indicated as an adjunct for the prevention of rejection in renal homotransplantation. experience with over 16,000 transplants shows a 5-year patient survival of 35% to 55%, but this is dependent on donor, match for hla antigens, anti-donor or anti b-cell alloantigen antibody, and other variables. the effect of azathioprine on these variables has not been tested in controlled trials. rheumatoid arthritis: azathioprine is indicated for the treatment of active rheumatoid arthritis (ra) to reduce signs and symptoms. aspirin, non-steroidal anti-inflammatory drugs and/or low dose glucocorticoids may be continued during treatment with azathioprine. the combined use of azathioprine with disease modifying anti-rheumatic drugs (dmards) has not been

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

golden state medical supply, inc. - azathioprine (unii: mrk240iy2l) (azathioprine - unii:mrk240iy2l) - indications and usage: azathioprine tablets are indicated as an adjunct for the prevention of rejection in renal homotransplantation. it is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms. renal homotransplantation: azathioprine tablets are indicated as an adjunct for the prevention of rejection in renal homotransplantation. experience with over 16,000 transplants shows a 5-year patient survival of 35% to 55%, but this is dependent on donor, match for hla antigens, anti-donor or anti b-cell alloantigen antibody, and other variables. the effect of azathioprine tablets on these variables has not been tested in controlled trials. rheumatoid arthritis: azathioprine istablets are indicated for the treatment of active rheumatoid arthritis (ra) to reduce signs and symptoms. aspirin, non-steroidal anti-inflammatory drugs and/or low dose glucocorticoids may be continued during treatment with azathioprine tablets. the combined use of azathioprine tablets with disease modifying anti-rheumatic drugs (dmards) has not been studied for either added benefit or unexpected adverse effects. the use of azathioprine with these agents cannot be recommended. contraindications: azathioprine tablets should not be given to patients who have shown hypersensitivity to the drug. azathioprine tablets should not be used for treating rheumatoid arthritis in pregnant women. patients with rheumatoid arthritis previously treated with alkylating agents (cyclophosphamide, chlorambucil, melphalan, or others) may have a prohibitive risk of malignancy if treated with azathioprine tablets.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - azathioprine (unii: mrk240iy2l) (azathioprine - unii:mrk240iy2l) - indications and usage: azathioprine is indicated as an adjunct for the prevention of rejection in renal homotransplantation. it is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms. renal homotransplantation: azathioprine is indicated as an adjunct for the prevention of rejection in renal homotransplantation. experience with over 16,000 transplants shows a 5-year patient survival of 35% to 55%, but this is dependent on donor, match for hla antigens, anti-donor or anti b-cell alloantigen antibody, and other variables. the effect of azathioprine on these variables has not been tested in controlled trials. rheumatoid arthritis: azathioprine is indicated for the treatment of active rheumatoid arthritis (ra) to reduce signs and symptoms. aspirin, non-steroidal anti-inflammatory drugs and/or low dose glucocorticoids may be continued during treatment with azathioprine. the combined use of azathioprine with disease modifying anti-rheumatic drugs (dmards) has not been

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - azathioprine - oral tablet - 25mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - azathioprine - oral tablet - 25mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - azathioprine - oral tablet - 25mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

ivax pharmaceuticals uk ltd - azathioprine - oral tablet - 25mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - azathioprine - oral tablet - 25mg